EQT Corporation (EQT) Stock Forecast
Data as of Jun 16, 2026Energy · Current price $51.41 (+1.29%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Dec 3, 2024 | Scott Hanold | RBC Capital | $49.00 | -4.7% |
| Oct 30, 2024 | Mike Scialla | Stephens | $38.00 | -26.1% |
| Oct 4, 2024 | Nitin Kumar | Mizuho Securities | $41.00 | -20.2% |
| Oct 3, 2024 | Scott Gruber | Citigroup | $44.00 | -14.4% |
| Sep 16, 2024 | Nitin Kumar | Mizuho Securities | $43.00 | -16.4% |
| Aug 22, 2024 | Paul Diamond | Citigroup | $37.00 | -28.0% |
| Aug 15, 2024 | Mark Lear | Piper Sandler | $32.00 | -37.8% |
| Aug 13, 2024 | Roger Read | Wells Fargo | $42.00 | -18.3% |
| Jul 25, 2024 | Mark Lear | Piper Sandler | $43.00 | -16.4% |
| Jul 18, 2024 | Mark Lear | Piper Sandler | $47.00 | -8.6% |
| Jul 12, 2024 | Cameron Bean | Scotiabank | $55.00 | +7.0% |
| Jun 30, 2024 | Lloyd Byrne | Jefferies | $49.00 | -4.7% |
| Jun 3, 2024 | Lloyd Byrne | Jefferies | $48.00 | -6.6% |
| May 24, 2024 | Stephen Richardson | Evercore ISI | $50.00 | -2.7% |
| May 13, 2024 | Phillip Jungwirth | BMO Capital | $47.00 | -8.6% |
| Apr 30, 2024 | Mark Lear | Piper Sandler | $46.00 | -10.5% |
| Apr 24, 2024 | Josh Silverstein | Wolfe Research | $46.00 | -10.5% |
| Apr 19, 2024 | Mark Lear | Piper Sandler | $41.00 | -20.2% |
| Apr 17, 2024 | Roger Read | Wells Fargo | $37.00 | -28.0% |
| Apr 16, 2024 | Nitin Kumar | Mizuho Securities | $40.00 | -22.2% |
Top Analysts Covering EQT
EQT vs Sector & Market
| Metric | EQT | Energy Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.11 | 2.53 | 2.41 |
| Analyst Count | 19 | 10 | 19 |
| Target Upside | -20.7% | +49.9% | +17.1% |
| P/E Ratio | 9.44 | 33.25 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $9.28B | $9.72B | $10.15B | 6 |
| 2027-03-31 | $2.54B | $2.69B | $2.88B | 2 |
| 2027-06-30 | $2.11B | $2.24B | $2.39B | 2 |
| 2027-09-30 | $2.22B | $2.36B | $2.52B | 2 |
| 2027-12-31 | $9.38B | $9.82B | $10.25B | 7 |
| 2028-03-31 | $2.56B | $2.73B | $2.88B | 1 |
| 2028-06-30 | $2.28B | $2.44B | $2.56B | 1 |
| 2028-09-30 | $2.45B | $2.62B | $2.75B | 1 |
| 2028-12-31 | $2.56B | $2.73B | $2.87B | 1 |
| 2029-03-31 | $6.03B | $6.44B | $6.78B | 2 |
| 2029-06-30 | $6.36B | $6.80B | $7.16B | 2 |
| 2029-09-30 | $6.71B | $7.17B | $7.55B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.97 | $4.88 | $5.73 | 13 |
| 2027-03-31 | $1.48 | $1.60 | $1.74 | 5 |
| 2027-06-30 | $0.82 | $0.89 | $0.97 | 5 |
| 2027-09-30 | $0.92 | $0.99 | $1.08 | 5 |
| 2027-12-31 | $3.94 | $4.95 | $6.07 | 14 |
| 2028-03-31 | $1.52 | $1.66 | $1.77 | 5 |
| 2028-06-30 | $1.12 | $1.22 | $1.30 | 7 |
| 2028-09-30 | $1.23 | $1.34 | $1.43 | 10 |
| 2028-12-31 | $1.44 | $1.57 | $1.67 | 5 |
| 2029-03-31 | $2.07 | $2.26 | $2.41 | 5 |
| 2029-06-30 | $1.58 | $1.73 | $1.85 | 7 |
| 2029-09-30 | $1.69 | $1.85 | $1.97 | 4 |
Frequently Asked Questions
What is the analyst consensus for EQT?
The consensus among 19 analysts covering EQT Corporation (EQT) is Buy with an average price target of $41.11.
What is the highest price target for EQT?
The highest price target for EQT is $65.00, set by Phillip Jungwirth at BMO Capital on 2022-09-20.
What is the lowest price target for EQT?
The lowest price target for EQT is $22.00, set by Neil Mehta at Goldman Sachs on 2021-04-20.
How many analysts cover EQT?
19 analysts have issued ratings for EQT Corporation in the past 12 months.
Is EQT a buy or sell right now?
Based on 19 analyst ratings, EQT has a consensus rating of Buy (2.11/5) with a -20.7% upside to the consensus target of $41.11.
What are the earnings estimates for EQT?
Analysts estimate EQT will report EPS of $4.88 for the period ending 2026-12-31, with revenue estimated at $9.72B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.